 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fennec Pharmaceuticals Inc (NASDAQ:FENC - Get Free Report) CEO Rosty Raykov sold 40,584 shares of the business's stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average...

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Sells 40,584 Shares of Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Equities research analysts at HC Wainwright dropped their Q2 2024 EPS estimates for shares of Fennec Pharmaceuticals in a note issued to...

HC Wainwright Comments on Fennec Pharmaceuticals Inc's Q2 2024 Earnings (NASDAQ:FENC)

Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)

Fennec Pharmaceuticals Inc CEO Rosty Raykov Sells 40,584 Shares

This is a signal that FENC's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Fennec Pharmaceuticals (FENC, $10.85) Stochastic Oscillator left the overbought zone on April 01, 2024

Over the last three days, A.I.dvisor has detected that FENC's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Fennec Pharmaceuticals (FENC, $10.85) Aroon Indicator entered an Uptrend on April 01, 2024.

Maxim Group analyst Jason McCarthy has maintained their bullish stance on FENC stock, giving a Buy rating on March 22. Jason McCarthy has given his...

Fennec Pharmaceuticals: A Strong Buy on PEDMARK's Success and Expansion Potential

Fennec Pharmaceuticals (FENC, $11.12) Aroon Indicator entered an Uptrend on March 28, 2024.

Fennec Pharmaceuticals Inc (NASDAQ:FENC  Get Free Report) CFO Robert Andrade sold 13,975 shares of the firms stock in a transaction on Monday, March 25th. The stock was sold at an...

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CFO Sells $153,725.00 in Stock

Fennec Pharmaceuticals (FENC, $11.09) Aroon Indicator entered an Uptrend on March 27, 2024.

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Volume (M)	143,207.00
52-Wk High	$11.92
52-Wk Low	$6.30

FENC Fennec Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals